Trials / Sponsors / EpiEndo Pharmaceuticals
EpiEndo Pharmaceuticals
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Clinical Trial Investigating the Effects of EP395 Following an Inhaled Endotoxin Challenge in Healthy Adults Healthy Volunteer | Phase 1 | 2025-02-20 |
| Completed | Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exp Chronic Obstructive Pulmonary Disease Exacerbation, COPD | Phase 1 | 2023-10-23 |
| Completed | Clinical Trial to Investigate the Safety and Tolerability of EP395 in Patients With COPD Chronic Obstructive Pulmonary Disease, COPD | Phase 2 | 2022-11-22 |
| Completed | Clinical Trial Comparing the Pharmacological Effects of EP395 With Placebo in Healthy Adults Chronic Obstructive Pulmonary Disease, COPD | Phase 1 | 2022-10-11 |
| Completed | Single and Multiple Ascending Dose Study With EP395 Adult ALL | Phase 1 | 2021-04-05 |